KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Non-Current Deferred Tax Liability (2016 - 2025)

Cardinal Health's Non-Current Deferred Tax Liability history spans 17 years, with the latest figure at $9.1 billion for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability rose 19.43% year-over-year to $9.1 billion; the TTM value through Dec 2025 reached $9.1 billion, up 19.43%, while the annual FY2025 figure was $8.9 billion, 10.54% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $9.1 billion at Cardinal Health, up from $8.7 billion in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $9.7 billion in Q3 2021 and bottomed at $700.0 million in Q1 2021.
  • The 5-year median for Non-Current Deferred Tax Liability is $8.5 billion (2023), against an average of $7.8 billion.
  • The largest YoY upside for Non-Current Deferred Tax Liability was 1272.43% in 2021 against a maximum downside of 91.85% in 2021.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $9.6 billion in 2021, then decreased by 8.43% to $8.8 billion in 2022, then dropped by 6.8% to $8.2 billion in 2023, then decreased by 6.84% to $7.6 billion in 2024, then rose by 19.43% to $9.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CAH's Non-Current Deferred Tax Liability are $9.1 billion (Q4 2025), $8.7 billion (Q3 2025), and $8.9 billion (Q2 2025).